339.20CHF-0.82%Mkt Cap: 308.01B $P/E: 21.151d ago
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Avg
P/B
Pricier
Div Yield
Lower
1M Perf
Avg
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
PHOO
Photocure ASA—
FLXN
Horizon Flexible Income ETF—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce—
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap308.01B $
Enterprise Value332.88B $
Revenue (TTM)72.31B $
Gross Profit53.31B $
Net Income (TTM)14.70B $
Revenue/Share90.84 USD
Last Price339.20 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012032048
Valuation
P/E (Trailing)21.15
P/E (Forward)15.50
PEG1.50
EV/EBITDA12.13
EV/Revenue4.60
P/S4.26
P/B7.98
EPS (TTM)16.04
EPS (Forward)21.88
52W Range
256.4065% of range383.00
52W High383.00 CHF
52W Low256.40 CHF
Profitability
Gross Margin73.73%
Oper. Margin29.99%
EBITDA Margin37.95%
Profit Margin20.33%
ROE38.10%
ROA12.79%
Growth
Revenue Growth-0.40%
Earnings Growth171.30%
Cash Flow & Leverage
Operating CF21.52B $
CapEx (TTM)6.60B $
FCF Margin17.41%
FCF Yield4.09%
Net Debt20.21B $
Net Debt/EBITDA0.74
Balance Sheet
Debt/Equity0.98
Current Ratio1.38
Quick Ratio1.05
Book Value/Sh42.48 CHF
Cash/Share19.46 CHF
Dividends
Fwd Div Rate9.800 CHF
Trail. Div Rate9.800 CHF
Div. Yield2.85%
5Y Avg Yield3.04%
Payout Ratio60.47%
Ex-Div DateMar 12, 2026
Pay DateMar 31, 2025
Splits
Last Split100:1
Split DateMay 4, 2011
Analyst Consensus
Rating—
Target (Mean)367.00 CHF
Upside (mean)+8.2%
Target Range340.00 CHF – 396.00 CHF
CHF340.00+8.2% to meanCHF396.00
# Analysts3
Ownership
Shares Out.106.69M
Float652.94M
Insiders72.31%
Institutions11.16%
Technical
SMA 50330.28 (+2.7%)
SMA 200326.63 (+3.8%)
Beta0.33
S&P 52W Chg20.05%
Avg Vol (30d)34.10K
Avg Vol (10d)26.42K
Technical Indicators
RSI (14)56.9
MACD2.3232
MACD Signal0.8252
MACD Hist.+1.4980
BB Upper344.88 CHF
BB Middle330.36 CHF
BB Lower315.84 CHF
BB Width8.79%
ATR (14)7.363 CHF
Vol Ratio (20d)1.28x